Publications of M. Bezler

Bezler, M.; Hengstler, J. G.; Ullrich, A.: Inhibition of doxorubicin-induced HER3-PI3K-AKT signalling enhances apoptosis of ovarian cancer cells. Molecular Oncology 6 (5), pp. 516 - 529 (2012)

Stoecklein, N. H.; Hosch, S. B.; Bezler, M.; Stern, F.; Hartmann, C. H.; Vay, C.; Siegmund, A.; Scheunemann, P.; Schurr, P.; Knoefel, W. T. et al.; Verde, P. E.; Reichelt, U.; Erbersdobler, A.; Grau, R.; Ullrich, A.; Izbicki, J. R.; Klein, C. A.: Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer. Cancer Cell 13 (5), pp. 441 - 453 (2008)

Ruhe, J. E.; Streit, S.; Hart, S.; Wong, C. H.; Specht, K.; Knyazev, P.; Knyazeva, T.; Tay, L. S.; Loo, H. L.; Foo, P. et al.; Wong, W.; Pok, S.; Lim, S. J.; Ong, H.; Luo, M.; Ho, H. V.; Peng, K.; Lee, T. C.; Bezler, M.; Mann, C.; Gaertner, S.; Hoefler, H.; Iacobelli, S.; Peter, S.; Tay, A.; Brenner, S.; Venkatesh, B.; Ullrich, A.: Genetic alterations in the tyrosine kinase transcriptome of human cancer cell lines. Cancer Research 67 (23), pp. 11368 - 11376 (2007)

Tanner, B.; Hasenclever, D.; Stern, K.; Schormann, W.; Bezler, M.; Hermes, M.; Brulport, M.; Bauer, A.; Schiffer, I. B.; Gebhard, S. et al.; Schmidt, M.; Steiner, E.; Sehouli, J.; Edelmann, J.; Lauter, J.; Lessig, R.; Krishnamurthi, K.; Ullrich, A.; Hengstler, J. G.: ErbB-3 predicts survival in ovarian cancer. Journal of Clinical Oncology 24 (26), pp. 4317 - 4323 (2006)

Bezler, M.: The HER3 receptor: Role as an intervention target in ovarian cancer. Dissertation, Technische Universität, München (2010)